Targeting amyloid aggregation: an overview of strategies and mechanisms
Amyloids result from the aggregation of a set of diverse proteins, due to either specific
mutations or promoting intra-or extra-cellular conditions. Structurally, they are rich in …
mutations or promoting intra-or extra-cellular conditions. Structurally, they are rich in …
Machado–Joseph disease/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy
CA Matos, LP de Almeida… - Journal of …, 2019 - Wiley Online Library
Abstract Machado–Joseph disease (MJD), also known as spinocerebellar ataxia type 3
(SCA 3), is an incurable disorder, widely regarded as the most common form of …
(SCA 3), is an incurable disorder, widely regarded as the most common form of …
Preclinical activities of epigallocatechin gallate in signaling pathways in cancer
Epigallocatechin gallate (EGCG) is the main bioactive component of catechins
predominantly present in various types of tea. EGCG is well known for a wide spectrum of …
predominantly present in various types of tea. EGCG is well known for a wide spectrum of …
Potential therapeutic use of plant flavonoids in AD and PD
S Meng-Zhen, L Ju, Z Lan-Chun, D Cai-Feng… - Heliyon, 2022 - cell.com
Background Millions of people suffer from Alzheimer's disease (AD) and Parkinson's
disease (PD) worldwide. Due to their complex pathology, no effective pharmacological …
disease (PD) worldwide. Due to their complex pathology, no effective pharmacological …
[HTML][HTML] Neurotheranostics as personalized medicines
The discipline of neurotheranostics was forged to improve diagnostic and therapeutic
clinical outcomes for neurological disorders. Research was facilitated, in largest measure …
clinical outcomes for neurological disorders. Research was facilitated, in largest measure …
The green tea polyphenolic catechin epigallocatechin gallate and neuroprotection
AR Khalatbary, E Khademi - Nutritional neuroscience, 2020 - Taylor & Francis
Epigallocatechin gallate is the most abundant composition of the tea catechins and is
thought to be responsible for the majority of biological activity of green tea extracts such as …
thought to be responsible for the majority of biological activity of green tea extracts such as …
Caenorhabditis elegans as a model system for target identification and drug screening against neurodegenerative diseases
L Ma, Y Zhao, Y Chen, B Cheng, A Peng… - European Journal of …, 2018 - Elsevier
Over the past decades, Caenorhabditis elegans (C. elegans) has been widely used as a
model system because of its small size, transparent body, short generation time and lifespan …
model system because of its small size, transparent body, short generation time and lifespan …
Protein misfolding and aggregation as a therapeutic target for polyglutamine diseases
T Takeuchi, Y Nagai - Brain sciences, 2017 - mdpi.com
The polyglutamine (polyQ) diseases, such as Huntington's disease and several types of
spinocerebellar ataxias, are a group of inherited neurodegenerative diseases that are …
spinocerebellar ataxias, are a group of inherited neurodegenerative diseases that are …
GST-4-Dependent Suppression of Neurodegeneration in C. elegans Models of Parkinson's and Machado-Joseph Disease by Rapeseed Pomace Extract …
F Pohl, A Teixeira-Castro, MD Costa… - Frontiers in …, 2019 - frontiersin.org
Genetic mutations and aging-associated oxidative damage underlie the onset and
progression of neurodegenerative diseases, like Parkinson's disease (PD) and Machado …
progression of neurodegenerative diseases, like Parkinson's disease (PD) and Machado …
Protein aggregation inhibitors as disease-modifying therapies for polyglutamine diseases
EN Minakawa, Y Nagai - Frontiers in neuroscience, 2021 - frontiersin.org
The polyglutamine (polyQ) diseases are a group of inherited neurodegenerative diseases
caused by the abnormal expansion of a CAG trinucleotide repeat that are translated into an …
caused by the abnormal expansion of a CAG trinucleotide repeat that are translated into an …